RA, rheumatoid arthritis

Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis
A Juurikivi, C Sandler, K A Lindstedt, P T Kovanen, T Juutilainen, M J Leskinen, T Mäki, K K Eklund

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1126-1131; DOI: 10.1136/ard.2004.029835
Treatment of experimental arthritis with poly(d, l-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate
M Higaki, T Ishihara, N Izumo, M Takatsu, Y Mizushima

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1132-1136; DOI: 10.1136/ard.2004.030759
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment
K Briot, P Garnero, A Le Henanff, M Dougados, C Roux

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1137-1140; DOI: 10.1136/ard.2004.028670
Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy
J Adriaansen, S W Tas, P L Klarenbeek, A C Bakker, F Apparailly, G S Firestein, C Jorgensen, M J B M Vervoordeldonk, P P Tak

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1677-1684; DOI: 10.1136/ard.2004.035063
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis
V P K Nell, K P Machold, T A Stamm, G Eberl, H Heinzl, M Uffmann, J S Smolen, G Steiner

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1731-1736; DOI: 10.1136/ard.2005.035691
Dendritic cells from patients with rheumatoid arthritis lack the interleukin 13 mediated increase of FcγRII expression, which has clear functional consequences
T R D J Radstake, K C A M Nabbe, M H Wenink, M F Roelofs, A Oosterlaar, A W T van Lieshout, P Barrera, P L E M van Lent, W B van den Berg

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1737-1743; DOI: 10.1136/ard.2004.034405
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression
J Rönnelid, M C Wick, J Lampa, S Lindblad, B Nordmark, L Klareskog, R F van Vollenhoven

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1744-1749; DOI: 10.1136/ard.2004.033571
Expression of interferon β in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis
J van Holten, T J M Smeets, P Blankert, P P Tak

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1780-1782; DOI: 10.1136/ard.2005.040477
High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities
M van Oosterhout, R J Verburg, E W N Levarht, J D Moolenburgh, R M Barge, W E Fibbe, J M van Laar

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1783-1785; DOI: 10.1136/ard.2004.034793
Swedish registers to examine drug safety and clinical issues in RA
J Askling, C M Fored, P Geborek, L T H Jacobsson, R van Vollenhoven, N Feltelius, S Lindblad, L Klareskog

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 707-712; DOI: 10.1136/ard.2005.045872

Main menu

RA, rheumatoid arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

RA, rheumatoid arthritis

Pages